LB PHARMACEUTICALS INC — Director's Dealing 2025

Sep 12, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: LB PHARMACEUTICALS INC (LBRX)
CIK: 0001691082
Period of Report: 2025-09-10

Reporting Person: Silva Richard Anthony (N/A)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (Right to Buy)	$41.84	2035-02-10	Common Stock (8964)		Direct

Footnotes

F1: One fourth (1/4) of the shares subject to the option award shall vest on February 10, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.